Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke
申请人:K and K Biosciences, Inc.
公开号:US20040073039A1
公开(公告)日:2004-04-15
Pharmaceutical compositions comprise as the active ingredient, nonneurotixic antiischemic compounds that are highly effective by the intraperitoneal route, and that are excitatory amino acid and NMDA/sigma receptor antagonists and are selected from the group consisting of those of the formulae,
1
wherein R
2
is 4-pyridyl, 3-pyridyl, or 2-oxo-
1
-pyrrolidino and R
1
is 3,4- or 3,5-dichloro, p- or m-chloro, p- or m-bromo, p- or m-fluoro, p- or m-trifluoromethyl, p-methyl, p-methoxy, or hydrogen, and those of the formulae,
2
wherein R
2
is 4-pyridyl or 3-pyridyl, R
3
is hydrogen, methyl or ethyl and R
1
is 3,4- or 3,5-dichloro, p- or m-chloro, p- or m-bromo, p- or m-fluoro, p- or m-trifluoromethyl, p-methyl, p-methoxy or hydrogen.
药物组合物包括非神经毒性抗缺血化合物作为活性成分,通过腹腔注射途径高效,且它们是兴奋性氨基酸和NMDA/sigma受体拮抗剂,并从下列组中选择:1式中R2为4-吡啶基、3-吡啶基或2-氧代-1-吡咯烷基,R1为3,4-或3,5-二氯、对-或间-氯、对-或间-溴、对-或间-氟、对-或间-三氟甲基、对-甲基、对-甲氧基或氢,以及2式中R2为4-吡啶基或3-吡啶基,R3为氢、甲基或乙基,R1为3,4-或3,5-二氯、对-或间-氯、对-或间-溴、对-或间-氟、对-或间-三氟甲基、对-甲基、对-甲氧基或氢。